A rare complication of central fascial paralysis associated with quinolone

Abstract

Quinolones, which are broad-spectrum antibiotics, are frequently preferred in the treatment of infections. In infections developing in immunosuppressed patients, side effects of quinolones, which are started empirically without determining the agent and etiology, are also quite common. In this article, central facial paralysis due to ciprofloxacin initiated for anal abscess in an immunosuppressed patient receiving chemotherapy for multiple myeloma is described, and we aim to draw attention to this rare side effect. To the best of our knowledge, this is the first case reported in the literature.

Keywords

• Central fascial paralysis
• quinolone
• ciprofloxacin

References

1. Shariati A, Arshadi M, Khosrojerdi MA, et al. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers Public Health. 2022;10:1025633. doi: 10.3389/fpubh.2022.1025633
2. Ali AK. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis. Ann Epidemiol. 2014;24(4):279-285.
3. Stahlmann R, Lode H. Toxicity of quinolones. Drugs. 1999; 58(Suppl 2):37-42.
4. Mennander AA. The dark side of fluoroquinolones. J Thoracic Cardiovasc Surg. 2019;157(1):122-123.
5. Refaeian A, Vest EL, Schmidt M, et al. Ciprofloxacin-induced peripheral neuropathy: a case report. HCA Healthcare J Med. 2023;4(5):7.
6. Bates D, Edwards J, Justin C, Fisher M, Switzer A, Morris C. Fluoroquinolone induced movement disorders: case report and literature review. Ulutas Med J. 2020;4(1):53-63.
7. Lee C-h, Cheung RT-f, Chan T-m. Ciprofloxacin-induced oral facial dyskinesia in a patient with normal liver and renal function. Hospital Med. 2000;61(2):142-143.
8. Azar S, Ramjiani A, Van Gerpen JA. Ciprofloxacin‐induced chorea. Movement Disord. 2005;20(4):513-514.

9. Isaacson SH, Carr J, Rowan AJ. Ciprofloxacin‐induced complex partial status epilepticus manifesting as an acute confusional state. Neurol. 1993;43(8):1619-1619.
10. Staff NP, Dyck PJB. On the association between fluoroquinolones and neuropathy. JAMA Neurol. 2019;76(7):753-754.
11. Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurol. 2014;83(14):1261-1263.
12. Manji H. Drug-induced neuropathies. Handbook Clin Neurol. 2013;115:729-742. doi.org/10.1016/B978-0-444-52902-2.00042-4
13. Jones MR, Urits I, Wolf J, et al. Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol. 2020;15(1): 38-48.
14. Morales D, Pacurariu A, Slattery J, Pinheiro L, McGettigan P, Kurz X. Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy. JAMA Neurol. 2019;76(7):827-833.
15. Cheung YF, Wong WWY, Tang KW, Chan JHM, Li PCK. Ciprofloxacin‐induced palatal tremor. Movement Disord. 2007;22(7):1038-1043.
16. Ben-Chetrit E, Rothstein N, Munter G. Ciprofloxacin-induced psychosis. Antimicrobial Agents Chemother. 2013;57(8):4079-4079.
17. Dukewich M, Danesh A, Onyima C, Gupta A. Intractable acute pain related to fluoroquinolone-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. 2017;31(2):144-147.
18. Estofan LJ, Naydin S, Gliebus G. Quinolone-induced painful peripheral neuropathy: a case report and literature review. J Investigative Med High Impact Case Reports. 2018;6:2324709617752736. doi:10.1177/2324709617752736